This class of small molecules acts as a bridge between CRBN and a set of neosubstrates required for the growth of hematologic tumors, such as multiple myeloma and myelodysplastic syndrome (14, 15, 16, 18, 23, 24, 25, 26, 27, 28, 29). Here, CRBN is linked to myelodysplastic syndrome.